China - Medicaments Of Other Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingMedicaments Of Other Antibiotics Prices in China
China Medicaments Of Other Antibiotics Import Price in September 2022
In September 2022, the medicaments of other antibiotics price stood at $107 per kg (CIF, China), which is down by -20.8% against the previous month. In general, the import price showed a abrupt curtailment. The growth pace was the most rapid in March 2022 when the average import price increased by 79% against the previous month. As a result, import price attained the peak level of $278K per ton. From April 2022 to September 2022, the average import prices remained at a lower figure.
There were significant differences in the average prices amongst the major supplying countries. In September 2022, the country with the highest price was Italy ($1.6K per kg), while the price for the United States ($9,052 per ton) was amongst the lowest.
From January 2022 to September 2022, the most notable rate of growth in terms of prices was attained by Italy (+44.5%), while the prices for the other major suppliers experienced more modest paces of growth.
China Medicaments Of Other Antibiotics Imports
In September 2022, supplies from abroad of medicaments of other antibiotics decreased by -26.9% to 803 tons, falling for the second month in a row after four months of growth. Overall, imports saw a relatively flat trend pattern. The pace of growth was the most pronounced in July 2022 with an increase of 99% month-to-month. As a result, imports attained the peak of 1.4K tons. From August 2022 to September 2022, the growth of imports failed to regain momentum.
In value terms, medicaments of other antibiotics imports contracted notably to $86M (IndexBox estimates) in September 2022. In general, imports recorded a abrupt shrinkage. The most prominent rate of growth was recorded in March 2022 when imports increased by 28% month-to-month. Over the period under review, imports attained the peak figure at 160K tons in July 2022; however, from August 2022 to September 2022, imports failed to regain momentum.
China Medicaments Of Other Antibiotics Imports by Country
In September 2022, the United States (514 tons) constituted the largest supplier of medicaments of other antibiotics to China, with a 64% share of total imports. Moreover, medicaments of other antibiotics imports from the United States exceeded the figures recorded by the second-largest supplier, Hong Kong SAR (84 tons), sixfold. The third position in this ranking was held by Japan (45 tons), with a 5.6% share.
From January 2022 to September 2022, the average monthly growth rate of volume from the United States amounted to +7.4%. The remaining supplying countries recorded the following average monthly rates of imports growth: Hong Kong SAR (-0.7% per month) and Japan (-6.6% per month).
In value terms, Ireland ($20M) constituted the largest supplier of medicaments of other antibiotics to China, comprising 23% of total imports. The second position in the ranking was taken by France ($9.8M), with an 11% share of total imports. It was followed by Hong Kong SAR, with an 8.3% share.
From January 2022 to September 2022, the average monthly growth rate of value from Ireland totaled -2.4%. The remaining supplying countries recorded the following average monthly rates of imports growth: France (+4.9% per month) and Hong Kong SAR (-1.8% per month).
This report provides an in-depth analysis of the market for medicaments of other antibiotics in China. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201150 - Medicaments of other antibiotics, n.p.r.s.
- Prodcom 21201180 - Medicaments of other antibiotics, p.r.s.
Country coverage:
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in China
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND THE AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDSThis Chapter is Available Only for the Professional EditionPRO
3. MARKET OVERVIEW
Understanding the Current State of The Market and its Prospects
- MARKET SIZE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET STRUCTURE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- TRADE BALANCE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- PER CAPITA CONSUMPTION: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET FORECAST TO 2035
4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION
Finding New Products to Diversify Your Business
- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCTS
- MOST TRADED PRODUCTS
- MOST PROFITABLE PRODUCTS FOR EXPORTS
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Export
- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
LIST OF FIGURES
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Volume Forecast to 2035
- Market Value Forecast to 2035
- Products: Market Size and Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports and Growth, By Type
- Products: Export Prices and Growth, By Type
- Production Volume and Growth
- Exports and Growth
- Export Prices and Growth
- Market Size and Growth
- Per Capita Consumption
- Imports and Growth
- Import Prices
- Production, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Production, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
158
This report provides an in-depth analysis of the market for medicaments of other antibiotics in China.
163
This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in China.
139
This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in China.
264
This report provides an in-depth analysis of the medicaments containing hormones market in China.
255
This report provides an in-depth analysis of the medicaments containing insulin market in China.
291
This report provides an in-depth analysis of the medicaments containing penicillin market in China.
180
This report provides an in-depth analysis of the global market for medicaments of other antibiotics.
227
This report provides an in-depth analysis of the global market for other medicaments for therapeutic or prophylactic uses.
304
This report provides an in-depth analysis of the global market for medicaments of alkaloids or derivatives thereof.
355
This report provides an in-depth analysis of the global medicaments containing hormones market.
188
Discover the top countries by import value of non-penicillin or streptomycin antibiotic medicaments in 2023. Explore key statistics and market insights.
267
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
127
Discover the top import markets for medicaments containing hormones, including Belgium, Denmark, United States, and more. Learn about the key players in the global market for hormone medications.
227
Pharmaceutical companies are fiercely competing in the obesity drug market, with Eli Lilly and Novo Nordisk among the major players. Innovations and collaborations are key in this dynamic and lucrative sector.
176
Novo Holdings finalizes $16.5 billion acquisition of Catalent, enhancing pharmaceutical capabilities amidst regulatory clearance.
188
Discover the top countries by import value of non-penicillin or streptomycin antibiotic medicaments in 2023. Explore key statistics and market insights.
267
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
127
Discover the top import markets for medicaments containing hormones, including Belgium, Denmark, United States, and more. Learn about the key players in the global market for hormone medications.
227
Pharmaceutical companies are fiercely competing in the obesity drug market, with Eli Lilly and Novo Nordisk among the major players. Innovations and collaborations are key in this dynamic and lucrative sector.
176
Novo Holdings finalizes $16.5 billion acquisition of Catalent, enhancing pharmaceutical capabilities amidst regulatory clearance.
